2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
作者信息
Galiè Nazzareno, Humbert Marc, Vachiery Jean-Luc, Gibbs Simon, Lang Irene, Torbicki Adam, Simonneau Gérald, Peacock Andrew, Vonk Noordegraaf Anton, Beghetti Maurice, Ghofrani Ardeschir, Gomez Sanchez Miguel Angel, Hansmann Georg, Klepetko Walter, Lancellotti Patrizio, Matucci Marco, McDonagh Theresa, Pierard Luc A, Trindade Pedro T, Zompatori Maurizio, Hoeper Marius
出版信息
Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29.
PMID:26320113
Abstract
摘要
相似文献
1
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29.
2
Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT).
Eur Heart J. 2009 Oct;30(20):2493-537. doi: 10.1093/eurheartj/ehp297. Epub 2009 Aug 27.
3
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).
Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29.
4
Diagnostics, monitoring and outpatient care in children with suspected pulmonary hypertension/paediatric pulmonary hypertensive vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
Heart. 2016 May;102 Suppl 2:ii1-13. doi: 10.1136/heartjnl-2015-307792.
5
[Pulmonary arterial hypertension associated with common diseases: connective-tissue diseases, HIV infection and portal hypertension].
Rev Prat. 2008 Nov 30;58(18):2011-8.
6
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
Eur Heart J. 2015 Nov 1;36(41):2793-2867. doi: 10.1093/eurheartj/ehv316. Epub 2015 Aug 29.
7
Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.
Eur Heart J. 2004 Dec;25(24):2243-78. doi: 10.1016/j.ehj.2004.09.014.
8
[Pulmonary arterial hypertension associated with connective tissue diseases].
Presse Med. 2014 Sep;43(9):957-69. doi: 10.1016/j.lpm.2014.07.009. Epub 2014 Aug 14.
9
Pulmonary hypertension in children with congenital heart disease (PAH-CHD, PPHVD-CHD). Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
Heart. 2016 May;102 Suppl 2:ii42-8. doi: 10.1136/heartjnl-2015-308378.
10
Recommendations on the management of pulmonary hypertension in clinical practice.
Heart. 2001 Sep;86 Suppl 1(Suppl 1):I1-13.
引用本文的文献
1
Evaluation of pulmonary hypertension in heart failure with preserved ejection fraction.
Heart Fail Rev. 2025 Sep 9. doi: 10.1007/s10741-025-10553-8.
2
Is splenectomy one of the contributory factors to pulmonary hypertension? An analysis of splenectomized hemolytic anemia and immune thrombocytopenia patients.
Ann Hematol. 2025 Sep 9. doi: 10.1007/s00277-025-06583-9.
3
Prevalence of Pulmonary Hypertension in Patients With Pulmonary Langerhans Cell Histiocytosis: A Systematic Review and Meta-Analysis.
Cureus. 2025 Jul 31;17(7):e89111. doi: 10.7759/cureus.89111. eCollection 2025 Jul.
4
Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine.
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251367312. doi: 10.1177/17534666251367312. Epub 2025 Aug 29.
5
Utility of inhaled nitric oxide for pulmonary hypertension in cyanotic congenital heart disease: a cohort study with propensity score matching.
Med Gas Res. 2026 Jun 1;16(2):93-97. doi: 10.4103/mgr.MEDGASRES-D-25-00062. Epub 2025 Aug 18.
6
An easily overlooked cause of pulmonary arterial hypertension-thiamine deficiency.
Front Nutr. 2025 Jul 31;12:1633864. doi: 10.3389/fnut.2025.1633864. eCollection 2025.
7
Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies.
Pulm Circ. 2025 Aug 14;15(3):e70140. doi: 10.1002/pul2.70140. eCollection 2025 Jul.
8
Right Ventricular Structure and Function in Patients with Primary Aldosteronism: A Cardiac Magnetic Resonance Study.
J Clin Med. 2025 Jul 29;14(15):5367. doi: 10.3390/jcm14155367.
9
Maternal and neonatal outcomes in pregnancies complicated with pulmonary hypertension: a retrospective cohort study.
Eur J Med Res. 2025 Aug 6;30(1):717. doi: 10.1186/s40001-025-02987-5.
10
A nomogram model for predicting maternal cardiovascular complications and neonatal adverse outcomes in pregnant patients with pulmonary arterial hypertension.
Ann Med. 2025 Dec;57(1):2541093. doi: 10.1080/07853890.2025.2541093. Epub 2025 Aug 4.
Zotero 插件